Why the study?
Does ethanol inhibit platelet-activating factor (PAF)-induced aggregation in human platelets?
Does ethanol inhibit platelet-activating factor (PAF)-induced aggregation in human platelets?
Ethanol selectively inhibits the secondary, arachidonic acid metabolite-dependent wave of PAF-induced platelet aggregation without affecting direct PAF-receptor interactions.
Ethanol may selectively blunt secondary PAF-induced platelet responses in animals; leaves open translation to human antithrombotic effects.
The interaction between ethanol and 1-0-alkyl-2-acetyl-sn-glycerol-3-phosphocholine (platelet activating factor, PAF) was addressed using platelets obtained from normal nonalcoholic volunteers. Ethanol at concentrations of 20 to 100 mM inhibited PAF activation of human platelets. Ethanol inhibited prominently the second or arachidonic acid metabolite dependent wave of platelet aggregation, which occurs with human platelets in citrated plasma. It also inhibited serotonin release and thromboxane A2 formation associated with this secondary phase of aggregation. Ethanol did not readily inhibit the primary wave of PAF-induced aggregation. The incorporation of PAF into platelets or metabolism of PAF was not influenced by up to 100 mM ethanol. Since ethanol inhibited only the secondary response, a direct interaction between PAF, ethanol, and a platelet PAF receptor is unlikely. The effect of ethanol on PAF-induced platelet aggregation shows a selectivity similar to that demonstrated by other investigators for epinephrine and adenosine diphosphate.
No takes yet. Share an insight, caveat, or question.
Baker et al. (1989) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: